Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Micromedic Technologies

Green Tea Extract EGCG Blocks Amyloid Plaque Formation in Brain Cell Cultures

By BiotechDaily International staff writers
Posted on 20 Mar 2013
Print article
The green tea extract, (−)-epigallocatechin-3-gallate (EGCG) prevented formation of metal-associated amyloid-beta plaques in brain cell cultures and dissolved plaques that had already formed.

EGCG is the most abundant catechin in tea and is a potent antioxidant that may have therapeutic applications in the treatment of many disorders. It is found in green tea but not black tea.

Alzheimer's disease investigators at the University of Michigan (Ann Arbor, USA) investigated and compared the interaction and reactivity of EGCG with metal (copper and zinc) and metal-free A-beta species. Such a study was considered necessary, as chelation therapy, which involves the removal of heavy metals from the body, has been shown to be beneficial in lowering amyloid plaque levels. This is because A-beta aggregation is somewhat dependent on the metal ions copper and zinc, and A-beta deposition was impeded in transgenic mice treated with the antibiotic clioquinol, a known copper/zinc chelator.

In the current study, a team comprising chemists, biochemists, and biophysicists used advanced analytical techniques including ion mobility-mass spectrometry (IM-MS), two-dimensional NMR spectroscopy, and computational methods to study the interaction of EGCG and A-beta plaques in cultures of human brain cells.

They reported in the February 20, 2013, online edition of the journal Proceedings of the National Academy of Sciences of the United States of America (PNAS) that EGCG interacted with metal-A-beta species and formed small, unstructured A-beta aggregates more noticeably than in metal-free conditions. Incubation of cells with EGCG eliminated the toxicity presented by both metal-free A-beta and metal-A-beta plaques. EGCG bound to A-beta monomers and dimers, generating more compact peptide conformations than those from EGCG-untreated A-beta species and nontoxic ternary EGCG-metal-A-beta complexes were produced.

"A lot of people are very excited about this molecule," said senior author Dr. Mi Hee Lim, assistant professor of chemistry at the University of Michigan. "We used a multidisciplinary approach. This is the first example of structure-centric, multidisciplinary investigations by three principal investigators with three different areas of expertise. But we believe you have to have a lot of approaches working together, because the brain is very complex. We want to modify them [molecules like EGCG] for the brain, specifically to interfere with the plaques associated with Alzheimer's."

Related Links:

University of Michigan




Print article

Channels

Drug Discovery

view channel
Image: Naturally occurring clay from Kisameet Bay, Canada, exhibits potent antibacterial activity against multidrug-resistant pathogens (Photo courtesy of Kisameet Glacial Clay Inc.).

Antibiotic Resistant Bacteria Succumb to Treatment with Unique Natural Clay

A team of Canadian medical microbiologists has demonstrated the potential use of a unique type of natural clay for treating pathogenic bacteria that have become resistant to the commonly used antibiotics.... Read more

Business

view channel

Purchase Agreement to Boost Ebola Vaccine Development

A deal to help boost development of a vaccine to protect against Ebolavirus infection was finalized at the recent Davos Conference in Switzerland. Gavi (Geneva, Switzerland), the global alliance for vaccines and immunizations, announced that it would spend five million USD to purchase the Ebola vaccine under development... Read more
Copyright © 2000-2016 Globetech Media. All rights reserved.